Kai-Michael Beeh

1.3k total citations
31 papers, 1.0k citations indexed

About

Kai-Michael Beeh is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Emergency Medical Services. According to data from OpenAlex, Kai-Michael Beeh has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 24 papers in Physiology and 3 papers in Emergency Medical Services. Recurrent topics in Kai-Michael Beeh's work include Asthma and respiratory diseases (24 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (20 papers) and Respiratory and Cough-Related Research (11 papers). Kai-Michael Beeh is often cited by papers focused on Asthma and respiratory diseases (24 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (20 papers) and Respiratory and Cough-Related Research (11 papers). Kai-Michael Beeh collaborates with scholars based in Germany, Canada and United Kingdom. Kai-Michael Beeh's co-authors include Roland Buhl, Patrick Micke, Andreas Faldum, Jan G. Hengstler, Fernando Bittinger, Frank Wagner, Stephanie Korn, Jutta Beier, Donald Banerji and Anne‐Marie Kirsten and has published in prestigious journals such as PLoS ONE, Journal of Allergy and Clinical Immunology and European Respiratory Journal.

In The Last Decade

Kai-Michael Beeh

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai-Michael Beeh Germany 14 675 518 285 240 114 31 1.0k
Shigenori Nakajima Japan 13 135 0.2× 193 0.4× 104 0.4× 76 0.3× 85 0.7× 52 448
Ryo Soda Japan 13 237 0.4× 156 0.3× 64 0.2× 59 0.2× 120 1.1× 57 595
Masamichi Itoga Japan 14 204 0.3× 271 0.5× 92 0.3× 62 0.3× 73 0.6× 47 595
Rory O’Donnell United Kingdom 10 505 0.7× 232 0.4× 89 0.3× 59 0.2× 207 1.8× 13 832
Kozo Ashida Japan 16 190 0.3× 196 0.4× 64 0.2× 56 0.2× 98 0.9× 46 700
Paul Rugman United Kingdom 10 407 0.6× 470 0.9× 67 0.2× 34 0.1× 131 1.1× 21 776
Susan Lu United States 17 751 1.1× 1.3k 2.4× 59 0.2× 57 0.2× 73 0.6× 42 1.6k
Elizabeth Joseloff United States 14 689 1.0× 93 0.2× 84 0.3× 93 0.4× 294 2.6× 21 1.0k
Tricia Finney‐Hayward United States 11 258 0.4× 126 0.2× 43 0.2× 177 0.7× 112 1.0× 25 661
Benedetto Violante Italy 11 297 0.4× 213 0.4× 90 0.3× 53 0.2× 67 0.6× 22 484

Countries citing papers authored by Kai-Michael Beeh

Since Specialization
Citations

This map shows the geographic impact of Kai-Michael Beeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai-Michael Beeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai-Michael Beeh more than expected).

Fields of papers citing papers by Kai-Michael Beeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai-Michael Beeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai-Michael Beeh. The network helps show where Kai-Michael Beeh may publish in the future.

Co-authorship network of co-authors of Kai-Michael Beeh

This figure shows the co-authorship network connecting the top 25 collaborators of Kai-Michael Beeh. A scholar is included among the top collaborators of Kai-Michael Beeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai-Michael Beeh. Kai-Michael Beeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Halpin, David, Sally Worsley, Afisi Ismaila, et al.. (2021). INTREPID: single-versusmultiple-inhaler triple therapy for COPD in usual clinical practice. ERJ Open Research. 7(2). 950–2020. 46 indexed citations
2.
3.
Marco, Fabiano Di, Giovanni Sotgiu, Pierachille Santus, et al.. (2018). Correction to: Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis. Respiratory Research. 19(1). 70–70. 2 indexed citations
4.
Kardos, Péter, et al.. (2018). Characterization of differential patient profiles and therapeutic responses of pharmacy customers for four ambroxol formulations. BMC Pharmacology and Toxicology. 19(1). 40–40. 13 indexed citations
5.
Beeh, Kai-Michael, Anne‐Marie Kirsten, Daniel Dusser, et al.. (2016). Pharmacodynamics and Pharmacokinetics Following Once-Daily and Twice-Daily Dosing of Tiotropium Respimat ® in Asthma Using Standardized Sample-Contamination Avoidance. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 29(5). 406–415. 19 indexed citations
6.
Beeh, Kai-Michael, Jan Westerman, Anne‐Marie Kirsten, et al.. (2015). The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics. 32. 53–59. 89 indexed citations
7.
8.
Beeh, Kai-Michael, Stephanie Korn, Jutta Beier, et al.. (2014). Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: The BRIGHT study. Respiratory Medicine. 108(4). 584–592. 97 indexed citations
9.
Beeh, Kai-Michael, Frank Kanniess, Frank Wagner, et al.. (2013). The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma. Journal of Allergy and Clinical Immunology. 131(3). 866–874. 141 indexed citations
10.
Vogelmeier, Claus, Leonardo M. Fabbri, Klaus F. Rabe, et al.. (2012). Effect of tiotropium vs. salmeterol on exacerbations: GOLD II and maintenance therapy naïve patients. Respiratory Medicine. 107(1). 75–83. 15 indexed citations
11.
Watz, Henrik, Daniel Bock, Michael C. Meyer, et al.. (2012). Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD. Pulmonary Pharmacology & Therapeutics. 26(2). 265–270. 42 indexed citations
12.
Beeh, Kai-Michael, et al.. (2011). Late-breaking abstract: Once-daily NVA237 improves exercise endurance from first dose in patients with COPD: The GLOW3 trial. European Respiratory Journal. 38(Suppl 55). 4497–4497. 2 indexed citations
13.
Watz, Henrik, Daniel Bock, Michael C. Meyer, et al.. (2011). Late-breaking abstract: Inhaled pan-selectin antagonist bimosiamose in COPD: A double-blind, randomized, placebo-controlled phase II study. European Respiratory Journal. 38(Suppl 55). 4492–4492. 2 indexed citations
14.
Beeh, Kai-Michael, Frank Wagner, Sanjeev Khindri, & Anton Drollmann. (2011). Effect of Indacaterol on Dynamic Lung Hyperinflation and Breathlessness in Hyperinflated Patients with COPD. COPD Journal of Chronic Obstructive Pulmonary Disease. 8(5). 340–345. 56 indexed citations
15.
Chipps, Bradley E., Roland Buhl, Kai-Michael Beeh, et al.. (2006). Improvement in quality of life with omalizumab in patients with severe allergic asthma. Current Medical Research and Opinion. 22(11). 2201–2208. 38 indexed citations
16.
Beier, Jutta, Kai-Michael Beeh, Oliver Kornmann, & Roland Buhl. (2004). Induced sputum methodology: validity and reproducibility of total glutathione measurement in supernatant of healthy and asthmatic individuals. Journal of Laboratory and Clinical Medicine. 144(1). 38–44. 17 indexed citations
17.
Micke, Patrick, Andreas Faldum, Kai-Michael Beeh, et al.. (2002). Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer—what limits limited disease?. Lung Cancer. 37(3). 271–276. 295 indexed citations
18.
Beeh, Kai-Michael, Tobias Welte, & Roland Buhl. (2002). Anticholinergics in the Treatment of Chronic Obstructive Pulmonary Disease. Respiration. 69(4). 372–379. 30 indexed citations
19.
Beeh, Kai-Michael & Roland Buhl. (2001). Pathogenese des Asthma bronchiale – Eröffnung neuer therapeutischer Perspektiven. Medizinische Klinik. 96(1). 15–25. 2 indexed citations
20.
Beeh, Kai-Michael, Tobias Welte, & Roland Buhl. (2000). Anticholinergika in der Therapie der chronisch-obstruktiven Lungenerkrankung (COPD). Medizinische Klinik. 95(10). 552–558. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigenori Nakajima Breakdown of academic impact, for papers by Ryo Soda Breakdown of academic impact, for papers by Masamichi Itoga Breakdown of academic impact, for papers by Rory O’Donnell Breakdown of academic impact, for papers by Kozo Ashida Breakdown of academic impact, for papers by Paul Rugman Breakdown of academic impact, for papers by Susan Lu Breakdown of academic impact, for papers by Elizabeth Joseloff Breakdown of academic impact, for papers by Tricia Finney‐Hayward Breakdown of academic impact, for papers by Benedetto Violante
Rankless by CCL
2026